Press Releases March 20, 2023 AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production Press Releases Related Articles July 8, 2026 Notice of Office Closure GeneDesign, Inc. – Osaka... June 23, 2026 Notice of Appointment of Directors GeneDesign, Inc. – Osaka... April 21, 2026 Impact of the Current Situation in the Middle East on Our Manufacturing Operations GeneDesign, Inc. – Osaka... April 16, 2026 Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing